The Evira Study: Additional Support During Obesity Treatment
Recruiting
N/A
Interventional Study
Childhood Obesity
Treatment Adherence
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
At a Glance
- Age
- 12 – 17
- Sex
- Any
- Study type
- Interventional
- Purpose
- Treatment
- Participants needed
- 40 (estimated)
- Sponsor
- Karolinska Institutet · Other
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
The goal of this clinical trial is to evaluate the effect of adding a digi-physical treatment tool as a complement to the local treatment with obesity medication in adolescents with obesity. The main question it aims to answer is:
\- Can a combination of a digi-physical treatment tool and obesity medication improve treatment outcomes for patients with obesity compared to patients treated with obe…
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
* Patients offered liraglutide or semaglutide in accordance with the clinic's routines.
* Aged 12-17 years at the time of inclusion.
* The family agrees to participate in a clinical study.
Exclusion Criteria:
* Endocrine disorders other than well-controlled hypothyroidism.
* S…
Contacts
Pernilla Danielsson Liljeqvist, Associate Professor
070-837 7734
pernilla.danielsson.liljeqvist@ki.se
CONTACT